Home  >  Products  >  LPP (LIM domain containing preferred translocation partner in lipoma) Blocking Peptide (the N terminal of protein) (100ug)
LPP (LIM domain containing preferred translocation partner in lipoma) Blocking Peptide (the N terminal of protein) (100ug)

LPP (LIM domain containing preferred translocation partner in lipoma) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-LPP antibody (Catalogue #: ARP53640_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP53640
Size: 100 ug
Weight: 67kDa
Gene: 4026
Format: Lyophilized powder
Target: LPP may play a structural role at sites of cell adhesion in maintaining cell shape and motility. In addition to these structural functions, it may also be implicated in signaling events and activation of gene transcription. LPP may be involved in signal transduction from cell adhesion sites to the nucleus allowing successful integration of signals arising from soluble factors and cell-cell adhesion sites. LPP is also suggested to serve as a scaffold protein upon which distinct protein complexes are assembled in the cytoplasm and in the nucleus.
See Full Product Listings >